Loading Events
EVENT
1 June
2018

Immuno-Oncology: BD&L and Investment Forum

TIME
8:00 am
LOCATION
WALDORF ASTORIA
11 E Walton
Chicago
IL
60611
United States
ATTENDING

Join us for the 4th Annual Immuno-Oncology: BD&L and Investment Forum

Taking place on the first day of ASCO, the 4th Annual Immuno-Oncology: BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. Expected: around 250 delegates and about 30 presentations by listed and private biotechnology companies seeking licensing & investment.

Plenary Sessions Include:

·        Industry Roundtable: Pharma-Biotech Pipeline

·        DealMaking and M&A

·        Latest Developments in IO & Combination Therapies

·        Cancer Vaccines and Neo Antigens: Evaluating Latest Progress

·        Advances in Cell & Gene Therapies

·        Early Stage Innovation

·        Investor Roundtable

Confirmed Keynotes Include:

·        ​Peter Kolchinsky, Managing Director, RA Capital Management

·        ​”Selective AXL Inhibition as a Potential Cornerstone of Combination Cancer Therapy” by Richard Godfrey, CEO, BerGenBio AS

·        ​Rajul Jain, Senior Director, Clinical Development, Kite Pharma, a Gilead Company

SHARE ARTICLE